Catalyst Wire Dossier Catalyst Wire Dossier

SB497115

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SB497115, covering 2012-06-04 to 2012-06-04. Get the full timeline:

Most recent: Clinical Trial Update: SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C [Phase 2]

See pricing